Hide Board Information

Show Board Information

Nuverra Environmental Solutions, Inc. NESCQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/14/2017 7:15:17 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Nuverra Environmental Solutions, Inc. (OTCMRKTS: NESCQ) Stock Message Board

1. NESCQ Company Profile

    

2. NESCQ Time & Sales

    

3. NESCQ Recent News

    

4. NESCQ Filings

    

5. NESCQ Financials

    

6. NESCQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Nuverra Environmental Solutions, Inc. NESCQ

Recent Articles

• Monument Mining's AGM: Key Highlights and Future Directions
• RetinalGenix Technologies Welcomes M. Cory Zwerling as New CFO
• ALT5 Sigma Corp Faces Investigation Over Securities Concerns
• Legal Alert: DeFi Technologies Class Action Lawsuit Update
• Market Updates: Key Stocks Drawing Investor Interest Today
• Hormel Foods Corporation Investors: Taking Action on Legal Rights
• Investigation on Nidec Corporation: Investors Aware of Claims
• Brookfield Corporation Unveils C$1 Billion Medium-Term Notes
• Marquis Software Faces Data Breach Concerns Affecting Customers
• California Consumers Face $59 Billion Gas Overcharge Crisis
• Cali-Power Football Team Triumphs in Court Over Title Rights
• Ascentage Pharma Showcases Long-Term Efficacy Data for Olverembatinib
• Promising Results from Phase III POLARIS-1 Study of Olverembatinib
• Promising New Data on Olverembatinib for CML Treatment
• Promising Update on Olverembatinib for CML-CP Patients
• Olverembatinib's Significant Long-Term Impact for CML Patients
• CoreWeave, Inc.: Investigating Claims and Market Impact
• Hong Kong Rallies Together to Rebuild After Tragic Fire
• RetinalGenix Welcomes M. Cory Zwerling as New CFO and Interim COO
• Star Group, L.P. Sees Growth in 2025 Financial Results
• Star Group, L.P. Achieves Revenue Growth in Fiscal 2025
• Shaquille O'Neal's Innovative Journey from Basketball to Tech
• BioArctic's Leqembi Listed as Innovative Drug in China
• Innovent Biologics Delivers Breakthrough in Psoriasis Treatment
• Vermilion Energy Expands Financial Strategy Through Share Sales
• Morgan Dudley Joins Stargaze as Creative Advisor for New Era
• Understanding the Securities Class Action for Telix Pharmaceuticals
• Trump's Involvement in Paramount's Bid for Warner Bros. Discovery
• Investing in Deutsche Bank: Strong Returns Over Five Years
• Transform Your Investment: The Journey of $1000 in OEF Growth
• BioArctic's Leqembi Approved for China's Innovative Drug List
• Urgent Call for Global Health Funding to Prevent Child Deaths
• LEQEMBI's Inclusion in China's Innovative Drug List: Impact and Future
• Important Update for Synopsys Investors on Class Action Steps
• JAX's $30 Million Initiative to Transform Drug Safety Testing
• Discover the Growth of a $1000 Investment in Stryker Today
• Gates Foundation Calls for Action to Combat Child Mortality Rise
• Exciting Growth for Club Med: New Resort at Tremblant
• Kia PV5 Cargo: Leading the Charge in Commercial Van Safety
• Todd Warrick Takes Charge as Triangle Market President
• Trulieve Secures Major Funding with US$100 Million Notes Offering
• Innovative AI Project by Jackson Laboratory to Improve Drug Safety
• Ilene Fennoy, MD Recognized as Leader in Pediatric Healthcare
• James W. Edlund, MD: Celebrating a Legacy of Wound Care
• FOMC's Rate Decision and Major Earnings Reports Ahead
• Paramount Steps Up to Challenge Netflix Over Warner Bros Deal
• Investors Urged to Act: Fiserv Class Action Lawsuit Update
• TDECU Welcomes New Directors for Enhanced Leadership Team
• Investors Urged to Join Class Actions Against DexCom and CarMax
• Urgent Notice for James Hardie Industries plc Investors